Rabies Human Monoclonal antibody 50/100 IU

This product contains monoclonal antibodies targeting the rabies virus and is used for post-exposure prophylaxis (PEP) in suspected rabies exposure. It offers an alternative to traditional rabies immunoglobulin (RIG), with advantages like reduced risk of allergic reactions and consistent potency. Administered as a single dose, it is infiltrated around the wound site, often along with the rabies vaccine. It ensures immediate passive immunity while the vaccine induces active, long-term immunity against rabies.